Latest Insider Transactions at Jazz Pharmaceuticals PLC (JAZZ)
This section provides a real-time view of insider transactions for Jazz Pharmaceuticals PLC (JAZZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Jazz Pharmaceuticals plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Jazz Pharmaceuticals plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
SELL
Open market or private sale
|
Direct |
7,080
-4.03%
|
$984,120
$139.11 P/Share
|
|
Mar 05
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,905
-4.42%
|
$262,890
$138.95 P/Share
|
|
Mar 05
2025
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,088
-7.92%
|
$564,144
$138.95 P/Share
|
|
Mar 05
2025
|
Philip L Johnson EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,149
-2.24%
|
$158,562
$138.95 P/Share
|
|
Mar 05
2025
|
Renee D Gala President & COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,704
-6.03%
|
$787,152
$138.95 P/Share
|
|
Mar 05
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,239
-5.55%
|
$722,982
$138.95 P/Share
|
|
Mar 05
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,251
-4.79%
|
$3,070,638
$138.95 P/Share
|
|
Mar 03
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,500
-1.38%
|
$936,000
$144.25 P/Share
|
|
Feb 28
2025
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
773
-7.54%
|
$110,539
$143.29 P/Share
|
|
Feb 27
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
26,577
+12.88%
|
-
|
|
Feb 27
2025
|
Mary Elizabeth Henderson SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
9,244
+17.62%
|
-
|
|
Feb 27
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,719
+18.02%
|
-
|
|
Feb 27
2025
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
34,666
+16.33%
|
-
|
|
Feb 27
2025
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,889
+21.97%
|
-
|
|
Feb 27
2025
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
868
-5.41%
|
$123,256
$142.43 P/Share
|
|
Feb 27
2025
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,813
-19.5%
|
$693,072
$144.42 P/Share
|
|
Feb 27
2025
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,813
+14.82%
|
$567,934
$118.23 P/Share
|
|
Feb 27
2025
|
Philip L Johnson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,111
+19.61%
|
-
|
|
Feb 27
2025
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,296
+15.76%
|
-
|
|
Feb 27
2025
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,800
-10.24%
|
$547,200
$144.87 P/Share
|
|
Feb 27
2025
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,814
+6.15%
|
-
|
|
Feb 03
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-0.34%
|
$183,000
$122.31 P/Share
|
|
Jan 17
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,840
-3.04%
|
$1,688,480
$122.62 P/Share
|
|
Jan 17
2025
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,559
+6.1%
|
-
|
|
Jan 17
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-3.12%
|
$266,082
$122.62 P/Share
|
|
Jan 17
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
7,506
+9.69%
|
-
|
|
Jan 17
2025
|
Renee D Gala President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,300
-5.22%
|
$402,600
$122.62 P/Share
|
|
Jan 17
2025
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
7,741
+10.91%
|
-
|
|
Jan 17
2025
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,641
+16.61%
|
-
|
|
Jan 17
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,365
-5.1%
|
$166,530
$122.62 P/Share
|
|
Jan 17
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,533
+8.64%
|
-
|
|
Jan 17
2025
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,905
-4.88%
|
$232,410
$122.62 P/Share
|
|
Jan 17
2025
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,864
+13.06%
|
-
|
|
Jan 02
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-0.35%
|
$184,500
$123.43 P/Share
|
|
Dec 05
2024
|
Renee D Gala President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
80
-0.14%
|
$9,840
$123.45 P/Share
|
|
Dec 02
2024
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,000
-0.47%
|
$242,000
$121.17 P/Share
|
|
Dec 02
2024
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
53
-0.8%
|
$6,466
$122.49 P/Share
|
|
Nov 08
2024
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,700
-10.07%
|
$455,100
$123.41 P/Share
|
|
Nov 01
2024
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.23%
|
$110,000
$110.84 P/Share
|
|
Sep 06
2024
|
Mary Elizabeth Henderson SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
1,410
-8.85%
|
$152,280
$108.3 P/Share
|
|
Aug 06
2024
|
Heather Ann Mc Sharry Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,608
-7.84%
|
$178,488
$111.35 P/Share
|
|
Aug 06
2024
|
Kenneth W O'Keefe Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,484
-5.22%
|
$164,724
$111.35 P/Share
|
|
Aug 06
2024
|
Anne O Riordan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,484
-9.11%
|
$164,724
$111.35 P/Share
|
|
Aug 06
2024
|
Norbert G Riedel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,484
-21.8%
|
$164,724
$111.35 P/Share
|
|
Aug 06
2024
|
Mark Douglas Smith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,484
-13.98%
|
$164,724
$111.35 P/Share
|
|
Aug 06
2024
|
Rick E Winningham Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,484
-10.47%
|
$164,724
$111.35 P/Share
|
|
Aug 06
2024
|
Jennifer E. Cook Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,484
-13.98%
|
$164,724
$111.35 P/Share
|
|
Aug 02
2024
|
Patrick G Enright Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,731
+13.13%
|
-
|
|
Aug 02
2024
|
Heather Ann Mc Sharry Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,731
+15.39%
|
-
|
|
Aug 02
2024
|
Kenneth W O'Keefe Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,731
+11.59%
|
-
|